Alembic Pharmaceuticals to foray into Algerian market

Alembic Global Holding to invest in Adwiya Mami SARL Algeria

Alembic Pharmaceuticals announced that the Company's 100% subsidiary Alembic Global Holding has entered into a joint venture deal with Adwiya Mami SARL Algeria.

The deal envisages investment by AGH to the extent of 49% equity of Adwiya Mami. Post conclusion of the deal, the Company will be renamed as Alembic Mami SPA.

Adwiya Mami owns a state of art formulation plant with capacity of 1.2 billion per annum oral solids. The plant has been designed and developed by a leading European Pharmaceutical company in line with the cGMP requirements. The plant has enough headroom for future expansion.

Powered by Capital Market - Live News